Skip to content
Trial Eligibility
Menu

A Randomized Multicenter Study for Isolated Skin Vasculitis

NCT02939573

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Primary Cutaneous Vasculitis
  • Cutaneous Polyarteritis Nodosa
  • IgA Vasculitis
  • Henoch-Schönlein Purpura

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
August 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Kansas · 1

  • University of Kansas Medical Center · Kansas City, KS

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Texas · 1

  • UT Southwestern Medical Center · Dallas, TX

Virginia · 1

  • University of Virginia · Charlottesville, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.